Lv5
1093 积分 2025-12-26 加入
The comparative efficacy of 12-mo of alendronate and raloxifene in maintaining denosumab-induced improvement in peripheral volumetric BMD, microarchitecture, and estimated strength
3天前
已完结
Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses
3天前
已完结
The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension
3天前
已完结
Impact of denosumab on muscle health in older adults in long-term care
3天前
已完结
Denosumab for osteoporosis in older adults in long‐term care: A randomized trial
3天前
已完结
Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial
3天前
已完结
Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption
3天前
已完结
Sequential therapy with denosumab and zoledronate for osteoporosis management a randomized controlled trial
6天前
已完结
Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting
6天前
已完结
Therapeutic Strategies of Denosumab Sequential Therapy: A Four‐Armed Randomized Controlled Trial
6天前
已完结
皖公网安备34019202002308
